Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Particle Therapy Systems Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Particle Therapy Systems Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 170 Pages
Report ld: 5347720
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Particle Therapy Systems market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Particle Therapy Systems is a kind of external beam radiotherapy that uses positively charged particles such as protons and carbon ions instead of photons.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Particle Therapy Systems market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- IBA
- ViewRay Technologies
- Hitachi
- iCAD
- IsoRay
- Mevion Medical Systems
- Panacea Medical Technologies
- P-cure
- ZEISS Group
- Siemens
- Elekta
- Accuray Incorporated
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Cyclotrons
- Synchrotrons
- Synchrocyclotron
Segment by Application
- External Beam Radiotherapy
- Internal Beam Radiotherapy/Brachytherapy
CHAPTER OUTLINE
Chapter 1: Defines the Particle Therapy Systems study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Particle Therapy Systems: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Particle Therapy Systems Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Cyclotrons
1.2.3 Synchrotrons
1.2.4 Synchrocyclotron
1.3 Market Segmentation by Application
1.3.1 Global Particle Therapy Systems Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 External Beam Radiotherapy
1.3.3 Internal Beam Radiotherapy/Brachytherapy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Particle Therapy Systems Revenue Estimates and Forecasts 2020-2031
2.2 Global Particle Therapy Systems Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Particle Therapy Systems Sales Estimates and Forecasts 2020-2031
2.4 Global Particle Therapy Systems Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Particle Therapy Systems Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Particle Therapy Systems Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Cyclotrons Market Size by Manufacturers
3.5.2 Synchrotrons Market Size by Manufacturers
3.5.3 Synchrocyclotron Market Size by Manufacturers
3.6 Global Particle Therapy Systems Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Particle Therapy Systems Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Particle Therapy Systems Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Particle Therapy Systems Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Particle Therapy Systems Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Particle Therapy Systems Sales and Revenue by Type (2020-2031)
6.4 North America Particle Therapy Systems Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Particle Therapy Systems Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Particle Therapy Systems Sales and Revenue by Type (2020-2031)
7.4 Europe Particle Therapy Systems Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Particle Therapy Systems Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Particle Therapy Systems Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Particle Therapy Systems Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Particle Therapy Systems Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Particle Therapy Systems Sales and Revenue by Type (2020-2031)
9.4 Central and South America Particle Therapy Systems Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Particle Therapy Systems Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Particle Therapy Systems Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Particle Therapy Systems Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Particle Therapy Systems Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 IBA
11.1.1 IBA Corporation Information
11.1.2 IBA Business Overview
11.1.3 IBA Particle Therapy Systems Product Models, Descriptions and Specifications
11.1.4 IBA Particle Therapy Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 IBA Particle Therapy Systems Sales by Product in 2024
11.1.6 IBA Particle Therapy Systems Sales by Application in 2024
11.1.7 IBA Particle Therapy Systems Sales by Geographic Area in 2024
11.1.8 IBA Particle Therapy Systems SWOT Analysis
11.1.9 IBA Recent Developments
11.2 ViewRay Technologies
11.2.1 ViewRay Technologies Corporation Information
11.2.2 ViewRay Technologies Business Overview
11.2.3 ViewRay Technologies Particle Therapy Systems Product Models, Descriptions and Specifications
11.2.4 ViewRay Technologies Particle Therapy Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 ViewRay Technologies Particle Therapy Systems Sales by Product in 2024
11.2.6 ViewRay Technologies Particle Therapy Systems Sales by Application in 2024
11.2.7 ViewRay Technologies Particle Therapy Systems Sales by Geographic Area in 2024
11.2.8 ViewRay Technologies Particle Therapy Systems SWOT Analysis
11.2.9 ViewRay Technologies Recent Developments
11.3 Hitachi
11.3.1 Hitachi Corporation Information
11.3.2 Hitachi Business Overview
11.3.3 Hitachi Particle Therapy Systems Product Models, Descriptions and Specifications
11.3.4 Hitachi Particle Therapy Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Hitachi Particle Therapy Systems Sales by Product in 2024
11.3.6 Hitachi Particle Therapy Systems Sales by Application in 2024
11.3.7 Hitachi Particle Therapy Systems Sales by Geographic Area in 2024
11.3.8 Hitachi Particle Therapy Systems SWOT Analysis
11.3.9 Hitachi Recent Developments
11.4 iCAD
11.4.1 iCAD Corporation Information
11.4.2 iCAD Business Overview
11.4.3 iCAD Particle Therapy Systems Product Models, Descriptions and Specifications
11.4.4 iCAD Particle Therapy Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 iCAD Particle Therapy Systems Sales by Product in 2024
11.4.6 iCAD Particle Therapy Systems Sales by Application in 2024
11.4.7 iCAD Particle Therapy Systems Sales by Geographic Area in 2024
11.4.8 iCAD Particle Therapy Systems SWOT Analysis
11.4.9 iCAD Recent Developments
11.5 IsoRay
11.5.1 IsoRay Corporation Information
11.5.2 IsoRay Business Overview
11.5.3 IsoRay Particle Therapy Systems Product Models, Descriptions and Specifications
11.5.4 IsoRay Particle Therapy Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 IsoRay Particle Therapy Systems Sales by Product in 2024
11.5.6 IsoRay Particle Therapy Systems Sales by Application in 2024
11.5.7 IsoRay Particle Therapy Systems Sales by Geographic Area in 2024
11.5.8 IsoRay Particle Therapy Systems SWOT Analysis
11.5.9 IsoRay Recent Developments
11.6 Mevion Medical Systems
11.6.1 Mevion Medical Systems Corporation Information
11.6.2 Mevion Medical Systems Business Overview
11.6.3 Mevion Medical Systems Particle Therapy Systems Product Models, Descriptions and Specifications
11.6.4 Mevion Medical Systems Particle Therapy Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Mevion Medical Systems Recent Developments
11.7 Panacea Medical Technologies
11.7.1 Panacea Medical Technologies Corporation Information
11.7.2 Panacea Medical Technologies Business Overview
11.7.3 Panacea Medical Technologies Particle Therapy Systems Product Models, Descriptions and Specifications
11.7.4 Panacea Medical Technologies Particle Therapy Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Panacea Medical Technologies Recent Developments
11.8 P-cure
11.8.1 P-cure Corporation Information
11.8.2 P-cure Business Overview
11.8.3 P-cure Particle Therapy Systems Product Models, Descriptions and Specifications
11.8.4 P-cure Particle Therapy Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 P-cure Recent Developments
11.9 ZEISS Group
11.9.1 ZEISS Group Corporation Information
11.9.2 ZEISS Group Business Overview
11.9.3 ZEISS Group Particle Therapy Systems Product Models, Descriptions and Specifications
11.9.4 ZEISS Group Particle Therapy Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 ZEISS Group Recent Developments
11.10 Siemens
11.10.1 Siemens Corporation Information
11.10.2 Siemens Business Overview
11.10.3 Siemens Particle Therapy Systems Product Models, Descriptions and Specifications
11.10.4 Siemens Particle Therapy Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Siemens Recent Developments
11.11 Elekta
11.11.1 Elekta Corporation Information
11.11.2 Elekta Business Overview
11.11.3 Elekta Particle Therapy Systems Product Models, Descriptions and Specifications
11.11.4 Elekta Particle Therapy Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Elekta Recent Developments
11.12 Accuray Incorporated
11.12.1 Accuray Incorporated Corporation Information
11.12.2 Accuray Incorporated Business Overview
11.12.3 Accuray Incorporated Particle Therapy Systems Product Models, Descriptions and Specifications
11.12.4 Accuray Incorporated Particle Therapy Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Accuray Incorporated Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Particle Therapy Systems Industry Chain
12.2 Particle Therapy Systems Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Particle Therapy Systems Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Particle Therapy Systems Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Particle Therapy Systems Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Particle Therapy Systems Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Particle Therapy Systems Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Particle Therapy Systems Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Particle Therapy Systems Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Particle Therapy Systems Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Particle Therapy Systems Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Particle Therapy Systems Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Particle Therapy Systems Sales by Region (2020-2025) & (K Units)
Table 8. Global Particle Therapy Systems Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Particle Therapy Systems Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Particle Therapy Systems Sales Share by Manufacturers (2020-2025)
Table 12. Global Particle Therapy Systems Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Particle Therapy Systems Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Particle Therapy Systems by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Particle Therapy Systems as of 2024)
Table 16. Global Particle Therapy Systems Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Particle Therapy Systems Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Particle Therapy Systems Manufacturing Base and Headquarters
Table 19. Global Particle Therapy Systems Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Particle Therapy Systems Sales by Type (2020-2025) & (K Units)
Table 23. Global Particle Therapy Systems Sales by Type (2026-2031) & (K Units)
Table 24. Global Particle Therapy Systems Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Particle Therapy Systems Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Particle Therapy Systems ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Particle Therapy Systems Sales by Application (2020-2025) & (K Units)
Table 29. Global Particle Therapy Systems Sales by Application (2026-2031) & (K Units)
Table 30. Particle Therapy Systems High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Particle Therapy Systems Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Particle Therapy Systems Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Particle Therapy Systems ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Particle Therapy Systems Growth Accelerators and Market Barriers
Table 37. North America Particle Therapy Systems Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Particle Therapy Systems Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Particle Therapy Systems Growth Accelerators and Market Barriers
Table 40. Europe Particle Therapy Systems Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Particle Therapy Systems Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Particle Therapy Systems Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Particle Therapy Systems Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Particle Therapy Systems Growth Accelerators and Market Barriers
Table 45. Southeast Asia Particle Therapy Systems Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Particle Therapy Systems Investment Opportunities and Key Challenges
Table 47. Central and South America Particle Therapy Systems Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Particle Therapy Systems Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Particle Therapy Systems Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. IBA Corporation Information
Table 51. IBA Description and Major Businesses
Table 52. IBA Product Models, Descriptions and Specifications
Table 53. IBA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. IBA Sales Value Proportion by Product in 2024
Table 55. IBA Sales Value Proportion by Application in 2024
Table 56. IBA Sales Value Proportion by Geographic Area in 2024
Table 57. IBA Particle Therapy Systems SWOT Analysis
Table 58. IBA Recent Developments
Table 59. ViewRay Technologies Corporation Information
Table 60. ViewRay Technologies Description and Major Businesses
Table 61. ViewRay Technologies Product Models, Descriptions and Specifications
Table 62. ViewRay Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. ViewRay Technologies Sales Value Proportion by Product in 2024
Table 64. ViewRay Technologies Sales Value Proportion by Application in 2024
Table 65. ViewRay Technologies Sales Value Proportion by Geographic Area in 2024
Table 66. ViewRay Technologies Particle Therapy Systems SWOT Analysis
Table 67. ViewRay Technologies Recent Developments
Table 68. Hitachi Corporation Information
Table 69. Hitachi Description and Major Businesses
Table 70. Hitachi Product Models, Descriptions and Specifications
Table 71. Hitachi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Hitachi Sales Value Proportion by Product in 2024
Table 73. Hitachi Sales Value Proportion by Application in 2024
Table 74. Hitachi Sales Value Proportion by Geographic Area in 2024
Table 75. Hitachi Particle Therapy Systems SWOT Analysis
Table 76. Hitachi Recent Developments
Table 77. iCAD Corporation Information
Table 78. iCAD Description and Major Businesses
Table 79. iCAD Product Models, Descriptions and Specifications
Table 80. iCAD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. iCAD Sales Value Proportion by Product in 2024
Table 82. iCAD Sales Value Proportion by Application in 2024
Table 83. iCAD Sales Value Proportion by Geographic Area in 2024
Table 84. iCAD Particle Therapy Systems SWOT Analysis
Table 85. iCAD Recent Developments
Table 86. IsoRay Corporation Information
Table 87. IsoRay Description and Major Businesses
Table 88. IsoRay Product Models, Descriptions and Specifications
Table 89. IsoRay Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. IsoRay Sales Value Proportion by Product in 2024
Table 91. IsoRay Sales Value Proportion by Application in 2024
Table 92. IsoRay Sales Value Proportion by Geographic Area in 2024
Table 93. IsoRay Particle Therapy Systems SWOT Analysis
Table 94. IsoRay Recent Developments
Table 95. Mevion Medical Systems Corporation Information
Table 96. Mevion Medical Systems Description and Major Businesses
Table 97. Mevion Medical Systems Product Models, Descriptions and Specifications
Table 98. Mevion Medical Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Mevion Medical Systems Recent Developments
Table 100. Panacea Medical Technologies Corporation Information
Table 101. Panacea Medical Technologies Description and Major Businesses
Table 102. Panacea Medical Technologies Product Models, Descriptions and Specifications
Table 103. Panacea Medical Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Panacea Medical Technologies Recent Developments
Table 105. P-cure Corporation Information
Table 106. P-cure Description and Major Businesses
Table 107. P-cure Product Models, Descriptions and Specifications
Table 108. P-cure Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. P-cure Recent Developments
Table 110. ZEISS Group Corporation Information
Table 111. ZEISS Group Description and Major Businesses
Table 112. ZEISS Group Product Models, Descriptions and Specifications
Table 113. ZEISS Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. ZEISS Group Recent Developments
Table 115. Siemens Corporation Information
Table 116. Siemens Description and Major Businesses
Table 117. Siemens Product Models, Descriptions and Specifications
Table 118. Siemens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Siemens Recent Developments
Table 120. Elekta Corporation Information
Table 121. Elekta Description and Major Businesses
Table 122. Elekta Product Models, Descriptions and Specifications
Table 123. Elekta Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Elekta Recent Developments
Table 125. Accuray Incorporated Corporation Information
Table 126. Accuray Incorporated Description and Major Businesses
Table 127. Accuray Incorporated Product Models, Descriptions and Specifications
Table 128. Accuray Incorporated Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Accuray Incorporated Recent Developments
Table 130. Key Raw Materials Distribution
Table 131. Raw Materials Key Suppliers
Table 132. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 133. Milestones in Production Technology Evolution
Table 134. Distributors List
Table 135. Market Trends and Market Evolution
Table 136. Market Drivers and Opportunities
Table 137. Market Challenges, Risks, and Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Particle Therapy Systems Product Picture
Figure 2. Global Particle Therapy Systems Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Cyclotrons Product Picture
Figure 4. Synchrotrons Product Picture
Figure 5. Synchrocyclotron Product Picture
Figure 6. Global Particle Therapy Systems Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. External Beam Radiotherapy
Figure 8. Internal Beam Radiotherapy/Brachytherapy
Figure 9. Particle Therapy Systems Report Years Considered
Figure 10. Global Particle Therapy Systems Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Particle Therapy Systems Revenue (2020-2031) & (US$ Million)
Figure 12. Global Particle Therapy Systems Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Particle Therapy Systems Revenue Market Share by Region (2020-2031)
Figure 14. Global Particle Therapy Systems Sales (2020-2031) & (K Units)
Figure 15. Global Particle Therapy Systems Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Particle Therapy Systems Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Particle Therapy Systems Sales Volume Market Share in 2024
Figure 18. Global Particle Therapy Systems Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Cyclotrons Revenue Market Share by Manufacturer in 2024
Figure 21. Synchrotrons Revenue Market Share by Manufacturer in 2024
Figure 22. Synchrocyclotron Revenue Market Share by Manufacturer in 2024
Figure 23. Global Particle Therapy Systems Sales Market Share by Type (2020-2031)
Figure 24. Global Particle Therapy Systems Revenue Market Share by Type (2020-2031)
Figure 25. Global Particle Therapy Systems Sales Market Share by Application (2020-2031)
Figure 26. Global Particle Therapy Systems Revenue Market Share by Application (2020-2031)
Figure 27. North America Particle Therapy Systems Sales YoY (2020-2031) & (K Units)
Figure 28. North America Particle Therapy Systems Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Particle Therapy Systems Sales Revenue (US$ Million) in 2024
Figure 30. North America Particle Therapy Systems Sales Volume (K Units) by Type (2020- 2031)
Figure 31. North America Particle Therapy Systems Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Particle Therapy Systems Sales Volume (K Units) by Application (2020-2031)
Figure 33. North America Particle Therapy Systems Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Particle Therapy Systems Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Particle Therapy Systems Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Particle Therapy Systems Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Particle Therapy Systems Sales YoY (2020-2031) & (K Units)
Figure 38. Europe Particle Therapy Systems Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Particle Therapy Systems Sales Revenue (US$ Million) in 2024
Figure 40. Europe Particle Therapy Systems Sales Volume (K Units) by Type (2020-2031)
Figure 41. Europe Particle Therapy Systems Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Particle Therapy Systems Sales Volume (K Units) by Application (2020-2031)
Figure 43. Europe Particle Therapy Systems Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Particle Therapy Systems Revenue (2020-2031) & (US$ Million)
Figure 45. France Particle Therapy Systems Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Particle Therapy Systems Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Particle Therapy Systems Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Particle Therapy Systems Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Particle Therapy Systems Sales YoY (2020-2031) & (K Units)
Figure 50. Asia-Pacific Particle Therapy Systems Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Particle Therapy Systems Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Particle Therapy Systems Sales Volume (K Units) by Type (2020- 2031)
Figure 53. Asia-Pacific Particle Therapy Systems Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Particle Therapy Systems Sales Volume (K Units) by Application (2020-2031)
Figure 55. Asia-Pacific Particle Therapy Systems Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Particle Therapy Systems Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Particle Therapy Systems Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Particle Therapy Systems Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Particle Therapy Systems Revenue (2020-2031) & (US$ Million)
Figure 60. India Particle Therapy Systems Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Particle Therapy Systems Sales YoY (2020-2031) & (K Units)
Figure 62. Central and South America Particle Therapy Systems Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Particle Therapy Systems Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Particle Therapy Systems Sales Volume (K Units) by Type (2021-2031)
Figure 65. Central and South America Particle Therapy Systems Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Particle Therapy Systems Sales Volume (K Units) by Application (2020-2031)
Figure 67. Central and South America Particle Therapy Systems Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Particle Therapy Systems Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Particle Therapy Systems Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Particle Therapy Systems Sales YoY (2020-2031) & (K Units)
Figure 71. Middle East and Africa Particle Therapy Systems Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Particle Therapy Systems Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Particle Therapy Systems Sales Volume (K Units) by Type (2021-2031)
Figure 74. South America Particle Therapy Systems Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Particle Therapy Systems Sales Volume (K Units) by Application (2020-2031)
Figure 76. Middle East and Africa Particle Therapy Systems Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Particle Therapy Systems Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Particle Therapy Systems Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Particle Therapy Systems Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Particle Therapy Systems Revenue (2020-2025) & (US$ Million)
Figure 81. Particle Therapy Systems Industry Chain Mapping
Figure 82. Regional Particle Therapy Systems Manufacturing Base Distribution (%)
Figure 83. Global Particle Therapy Systems Production Market Share by Region (2020-2031)
Figure 84. Particle Therapy Systems Production Process
Figure 85. Regional Particle Therapy Systems Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Particle Therapy Systems market?
The top companies in the global Particle Therapy Systems market are IBA、ViewRay Technologies、Hitachi.
Related Reports
Particle Therapy Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Particle Therapy Systems was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 145
USD 3950.00
(Single User License)
Global Particle Therapy Systems Market Research Report 2026
The global Particle Therapy Systems market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 118
USD 2900.00
(Single User License)
Global Particle Therapy Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Particle Therapy Systems market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 98
USD 4250.00
(Single User License)
Particle Therapy Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Particle Therapy Systems was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 124
USD 3950.00
(Single User License)
Global Particle Therapy Systems Market Research Report 2025
The global market for Particle Therapy Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 91
USD 2900.00
(Single User License)
Global Particle Therapy Systems Market Insights, Forecast to 2030
Particle Therapy Systems is a kind of external beam radiotherapy that uses positively charged particles such as protons and carbon ions instead of photons.
Published Date: 2024-04-10
Pages: 111
USD 4900.00
(Single User License)
Global Particle Therapy Systems Market Research Report 2024
Particle Therapy Systems is a kind of external beam radiotherapy that uses positively charged particles such as protons and carbon ions instead of photons.
Published Date: 2024-01-17
Pages: 89
USD 2900.00
(Single User License)
Particle Therapy Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Particle Therapy Systems was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 145
USD 3950.00 (Single User License)Global Particle Therapy Systems Market Research Report 2026
The global Particle Therapy Systems market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 118
USD 2900.00 (Single User License)Global Particle Therapy Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Particle Therapy Systems market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 98
USD 4250.00 (Single User License)Particle Therapy Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Particle Therapy Systems was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 124
USD 3950.00 (Single User License)Global Particle Therapy Systems Market Research Report 2025
The global market for Particle Therapy Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 91
USD 2900.00 (Single User License)Global Particle Therapy Systems Market Insights, Forecast to 2030
Particle Therapy Systems is a kind of external beam radiotherapy that uses positively charged particles such as protons and carbon ions instead of photons.
Published: 2024-04-10
Pages: 111
USD 4900.00 (Single User License)Global Particle Therapy Systems Market Research Report 2024
Particle Therapy Systems is a kind of external beam radiotherapy that uses positively charged particles such as protons and carbon ions instead of photons.
Published: 2024-01-17
Pages: 89
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now